Selecting treatment options for TKI-resistant chronic myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Antigens, CD34
  • Antigens, CD38
  • Antineoplastic Agents
  • Chromosome Aberrations
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Protein Kinase Inhibitors
  • Protein-Tyrosine Kinases

publication date

  • January 2014

Research

keywords

  • Academic Article

Additional Document Info

start page

  • 12

end page

  • 16

volume

  • 12

number

  • 7